 RVT-3101 demonstrated statistically significant and clinically meaningful efficacy at each dose tested Across all patients treated with RVT-3101, the clinical remission and endoscopic improvement rates were 32 and 40, respectively. Similar results were observed at the expected Phase 3 dose At the expected Phase 3 dose, among patients who were positive for a biomarker that ... The post Roivant Announces Statistically Significant and Clinically Meaningful Results from the Induction Period of TUS... 